Cargando…
Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-Thiacytidine
BACKGROUND: Antiretroviral drug discovery and formulation design will facilitate viral clearance in infectious reservoirs. Although progress has been realized for selected hydrophobic integrase and nonnucleoside reverse transcriptase inhibitors, limited success has been seen to date with hydrophilic...
Autores principales: | Guo, Dongwei, Zhou, Tian, Araínga, Mariluz, Palandri, Diana, Gautam, Nagsen, Bronich, Tatiana, Alnouti, Yazen, McMillan, JoEllyn, Edagwa, Benson, Gendelman, Howard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305294/ https://www.ncbi.nlm.nih.gov/pubmed/27559685 http://dx.doi.org/10.1097/QAI.0000000000001170 |
Ejemplares similares
-
ProTide generated long-acting abacavir nanoformulations
por: Lin, Zhiyi, et al.
Publicado: (2018) -
Creation of a long-acting nanoformulated dolutegravir
por: Sillman, Brady, et al.
Publicado: (2018) -
Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals
por: Zhou, Tian, et al.
Publicado: (2018) -
Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques
por: McMillan, JoEllyn, et al.
Publicado: (2017) -
Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
por: Zhou, Tian, et al.
Publicado: (2017)